|Description||Investing in Biomedical Innovation|
Whether you’re an entrepreneur or a venture capitalist, you’ll find a warm welcome at Triathlon Medical Ventures. Prior to opening our doors in 2004, Triathlon’s team has been investing in life science business opportunities for more than fifteen years. And we are also industry veterans, experienced at growing medical device and biotechnology companies from the inside out - as owners, directors and operational managers.
Triathlon Medical Ventures is a Midwest-based venture capital firm that invests exclusively in the life sciences. We provide equity capital to early and expansion stage companies with proprietary biomedical technology platforms or products addressing significant human healthcare needs.
|Tolera Therapeutics||10/12||Series B||$5.5M||3|
|Aerpio Therapeutics||8/12||Series A||$27M||6|
|Juventas Therapeutics||7/12||Series B||$22.2M||7|
|Akebia Therapeutics||1/12||Series B||$4.1M||7|
|CoLucid Pharmaceuticals||8/11||Venture Round||$7.5M||5|
|Akebia Therapeutics||4/11||Series B||$22M||7|
|Akebia Therapeutics||9/09||Series A||$16M||5|
|Tolera Therapeutics||6/08||Series A||3|